Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 331

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 331
---

    $(29,993,685) 
    $96,434  
    $24,630,465 
  
    Stock-based compensation 
     -  
     -  
     2,965,938  
     -  
     -  
     2,965,938 
  
    Reclassification adjustment for interest earned on marketable securities included in net loss 
     -  
     -  
     -  
     -  
     (430,993) 
     (430,993)
  
    Change in unrealized gain on marketable securities 
     -  
     -  
     -  
     -  
     334,559  
     334,559 
  
    Net loss 
     -  
     -  
     -  
     (15,423,471) 
     -  
     (15,423,471)
  
    Balance, December 31, 2023 
     8,401,047  
    $84,011  
    $57,409,643  
    $(45,417,156) 
    $-  
    $12,076,498 
  
    Balance 
     8,401,047  
    $84,011  
    $57,409,643  
    $(45,417,156) 
    $-  
    $12,076,498 

    Stock-based compensation 
     -  
     -  
     2,305,849  
     -  
     -  
     2,305,849 
  
    Issuance of shares of common stock, net of issuance costs (Note 6b) 
     152,000  
     1,520  
     352,591  
     -  
     -  
     354,111 
  
    Issuance of shares of common stock and warrants, net of issuance costs (Note 6c) 
     1,643,837  
     16,438  
     2,445,532  
     -  
     -  
     2,461,970 
  
    Issuance of shares of common stock and warrants, net of issuance costs (Note 6d)